HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mixed connective tissue disease-enigma variations?

Abstract
In 1972, Sharp et al. described a new autoimmune rheumatic disease that they called MCTD, characterized by overlapping features of SSc, SLE, PM/DM, high levels of anti-U1snRNP and low steroid requirements with good prognosis. MCTD was proposed as a distinct disease. However, soon after the original description, questions about the existence of such a syndrome as well as disputes over the features initially described began to surface. The conundrum of whether MCTD is a distinct disease entity remains controversial. We undertook a literature review, focusing on the articles reporting new data about MCTD published in the last decade, to determine whether any new observations help to answer the conundrum of MCTD. After reviewing recent data, we question whether the term MCTD is appropriately retained, preferring to use the term undifferentiated autoimmune rheumatic disease.
AuthorsNatalia C O Ciang, Nídia Pereira, David A Isenberg
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 56 Issue 3 Pg. 326-333 (03 01 2017) ISSN: 1462-0332 [Electronic] England
PMID27436003 (Publication Type: Journal Article, Review)
Copyright© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Autoantibodies
  • Glucocorticoids
  • Immunosuppressive Agents
  • RNA, Small Nuclear
  • U1 small nuclear RNA
Topics
  • Arthritis (etiology, immunology)
  • Autoantibodies (immunology)
  • Esophageal Diseases (etiology, immunology)
  • Glomerulonephritis, Membranous (etiology, immunology)
  • Glucocorticoids (therapeutic use)
  • Humans
  • Hypertension, Pulmonary (etiology, immunology)
  • Immunosuppressive Agents (therapeutic use)
  • Lung Diseases, Interstitial (etiology, immunology)
  • Microscopic Angioscopy
  • Mixed Connective Tissue Disease (classification, complications, drug therapy, immunology)
  • Myositis (etiology, immunology)
  • Pericarditis (etiology, immunology)
  • RNA, Small Nuclear (immunology)
  • Raynaud Disease (etiology, immunology)
  • Vasodilation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: